Syndax Pharmaceuticals (SNDX) PT Raised to $38 at UBS

November 4, 2025 8:43 AM EST Send to a Friend

UBS analyst David Dai raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Syndax Pharmaceuticals (SNDX) PT Raised to $38 at UBS

Member Login

Free News Feed